GO
Loading...

Medicine

More

  • April 17- UnitedHealth Group Inc, the largest U.S. health insurer, said on Thursday it has spent more than $100 million to cover a pricey new hepatitis C drug from Gilead Sciences Inc, a higher cost than it expected by "multiples," sending shares in the sector lower.

  • New kind of trial aims to speed cancer drug development Wednesday, 16 Apr 2014 | 7:01 PM ET

    *AstraZeneca, Pfizer, UK charity link in multi-drug trial. Instead of testing one drug at a time, a novel lung cancer study announced on Thursday will allow British researchers to test up to 14 drugs from AstraZeneca and Pfizer at the same time within one trial.

  • Kansas to mandate some health coverage on autism Wednesday, 16 Apr 2014 | 5:01 AM ET

    OVERLAND PARK, Kan.— Kansas will require health insurance companies to cover services for hundreds of children with autism starting next year under a bill signed into law Wednesday by Gov. Brownback signed the bill in an auditorium on the satellite University of Kansas campus in Overland Park, the home of a center for autism research.

  • FDA approves injectable diabetes drug from Glaxo Tuesday, 15 Apr 2014 | 3:08 PM ET

    WASHINGTON— The Food and Drug Administration said Tuesday it approved a new injectable drug from GlaxoSmithKline plc for adults with Type 2 diabetes. The FDA said it approved the new drug based on eight trials including more than 2,000 patients.

  • Americans start spending on health care again Tuesday, 15 Apr 2014 | 7:06 AM ET

    Americans used more health services and spent more on prescription drugs in 2013, reversing a recent trend.

  • ZURICH, April 15- A strong uptake of new cancer medicines helped Roche to limit a decline in first-quarter sales and the Swiss company confirmed a forecast for higher earnings this year.

  • *Q1 sales 11.496 bln Swiss francs vs 11.887 bln forecast. ZURICH, April 15- Adverse currency moves weighed on first-quarter sales at Roche Holding AG, which fell 1 percent, despite a healthy uptake of its new cancer medicines.

  • Google Glass helped save patient's life: Surgeon Monday, 14 Apr 2014 | 1:05 PM ET
    A man wearing Google Glass at the headquarters of Google Belgium in Brussels.

    Google Glass might have another purpose than just entertaining. Dr Horng from Boston said that it helped saved a patient's life last January.

  • NEW YORK, April 14- There are many enterprises out there trying to separate you from your tax refund- from splurges such as airlines tickets for a celebratory vacation or for good purposes, like putting it all in a college savings account.

  • How Google Glass helped save a life     Monday, 14 Apr 2014 | 11:43 AM ET

    Dr. Steven Horng, Beth Israel Deaconess Medical Center, explains how Google Glass provided crucial support in an emergency situation and helped save a life.

  • April 14- Lexicon Pharmaceuticals Inc said its experimental drug to treat diabetes met the main goal of reducing the use of insulin at meal times in a mid-stage study on patients with type 1 diabetes. The company's shares rose 19.5 percent to $1.90 in trading before the bell.

  • April 14- Lexicon Pharmaceuticals Inc said its experimental drug to treat diabetes met the main goal of reducing the use of insulin at meal times in a mid-stage study on patients with type 1 diabetes. The company's shares rose about 19 percent to $1.89 in trading before the bell.

  • April 12- A drug being developed by Intercept Pharmaceuticals Inc led to significant improvement in signs of a rare liver disease that primarily affects middle-aged women, likely reducing the risk of need for liver transplant and of death, according to results of a late-stage clinical trial presented on Saturday.

  • LOS ANGELES/ LONDON April 11- Doctors at a key medical conference welcomed the prospect of more new drugs to treat the liver-destroying hepatitis C virus, while agreeing that Gilead Sciences Inc continues to lead the effort.

  • Mexican police issue 'ransom ware' virus warning Thursday, 10 Apr 2014 | 4:44 PM ET

    MEXICO CITY— Police in Mexico City have issued a warning about a new type of "ransom ware" virus that can take over computers' cameras and make the user think they are under surveillance. The Mexico City police department's cyber-crime unit says the virus infects computers, generally after they view or download sexually explicit material.

  • Hep C breakthrough     Thursday, 10 Apr 2014 | 2:53 PM ET

    CNBC contributor Barbara Ryan provides insight into new guidelines from the World Health Organization, which strongly endorses two new hepatitis c drugs.

  • WASHINGTON, April 10- The leading U.S. pharmaceutical industry trade group on Thursday defended the cost of Gilead Sciences Inc's new hepatitis C drug, Sovaldi, saying such treatments offer a priceless breakthrough for patients with the liver-destroying virus.

  • Maine Medicaid rules reduce narcotic prescriptions Thursday, 10 Apr 2014 | 12:01 PM ET

    PORTLAND, Maine— Maine's severe restrictions on opioid painkillers for Medicaid patients, requiring many to instead seek alternative pain management treatment for the past year, have sharply reduced the number of people obtaining highly addictive medications blamed for drug abuse and deaths around the nation.

  • MUMBAI, April 10- India's Natco Pharma Ltd has formally asked the Indian patent office to deny U.S. drugmaker Gilead Sciences Inc's new hepatitis C drug Sovaldi a patent in India, a source with direct knowledge of the matter said.

  • CNBC's Jim Cramer speaks with Robert Hugin, Celgene chairman & CEO, about America's need to build a stronger and more sustainable ecosystem of innovation to continue as the world leader in biomedical innovation.

Most Popular Video

Thursday, 17 Apr 2014 | 4:13 PM ET

Dissecting today's market activity and the current state of financials, with Yra Harris, Praxis Trading partner; Larry Glazer, Mayflower Advisors; CNBC contributor Carol Roth; "Fast Money" Guy Adami and CNBC's Kate Kelly.

Thursday, 17 Apr 2014 | 5:46 PM ET

CNBC voice over talent Jim Birdsall shares the top 5 sayings from traders on "Fast Money" over the years.

Thursday, 17 Apr 2014 | 6:40 PM ET

Mad Money's Jim Cramer reflects on CNBC's evolution over the past 25 years.